* Yitzchak Besser
Major pharmaceutical companies, like their peers in other industries, are often presumed to zealously guard their patents; in fact, patent litigation in the pharmaceutical industry rose nearly 30% in 2017 . Mike Botta, Report: Pharmaceutical Patent Litigation Increased Nearly 30 Percent in 2017, R&D (May 8, 2018, 7:00 AM), https://www.rdmag.com/news/2018/05/report-pharmaceutical-patent-litigation-increased-nearly-30-percent-2017. However, Allergan, Inc., has recently found itself in court for attempting to implement a novel approach toward safeguarding intellectual property: transferring ownership of their patents to a Native American tribe, and then filing for exemption from review under a theory of tribal sovereign immunity. Saint Regis Mohawk Tribe v. Mylan Pharms. Inc., 896 F.3d 1322, 1325 (Fed. Cir. 2018).Continue reading “Allergan’s Tribal Troubles: Sovereign Immunity and Patent Protection Measures in Saint Regis Mohawk Tribe v. Mylan Pharmaceuticals”
